| Execution period | 5 years |
|---|
BSE filing, NSE: ADIEXRE. Summary written from the filing by ALFA Finder's alert engine.
Trustedge Capital Ltd: key numbers
- Share price
- ₹114.90
- Market cap
- ₹106.0 Cr
- Revenue (annual)
- ₹5.22 Cr
- Net profit (annual)
- ₹0.55 Cr
- P/E (TTM)
- 61.6×Sector 19.7×
- Promoter holding
- 74.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trustedge Capital Ltd
All →Trustedge Capital Management Change
TrustEdge Capital appointed Mr. Suraj Bhadoriya as Chief Financial Officer, effective 26 October 2026, following a board meeting that day. He is a qualified Chartered Accountant with over four years of post-qualification finance experience.
Trustedge Capital Employee Stock Options
Trustedge Capital cancelled 3,000 unvested stock options under its TEDGE ESOS 2025 scheme. The cancellation involves no equity allotment and no change in share capital.
Trustedge Capital Financial Results
Trustedge Capital approved unaudited results for the quarter and half year ended September 30, 2026, with a limited review report. It also appointed Suraj Bhadoriya as CFO and KMP effective October 26, 2026.
Trustedge Capital Q2 FY27 Results: Turns Profitable, Net Profit ₹0.5 Cr
Trustedge Capital Ltd reported revenue from operations of ₹2.8 Cr (+211.1% YoY) and net profit of ₹0.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.5 Cr
Trustedge Capital Board Meeting Date
Trustedge Capital Limited has scheduled a board meeting on October 26, 2026, to consider and approve the company's unaudited financial results for the quarter ending September 2026.
Trustedge Capital Management Change
CFO Mr. Jayprakash Labhshankar Raval of Trustedge Capital Ltd has resigned, effective from the close of business hours on October 17, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.